Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2375-2383

  Stramer, Susan L ^a   Dodd, Roger Y ^b  

^a Scientific Support Office   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; DISEASE TRANSMISSION; HUMAN; PREVENTION AND CONTROL; TRANSMISSION; COMMUNICABLE DISEASE; NOTE;

BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; DISEASE TRANSMISSION, INFECTIOUS; HUMANS;

EID: 84891702001     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12371     Document Type: Note

References (39)

1. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KM, Dodd RY. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009;49(Suppl 2):1S-29S.
2. Dodd RY. Emerging infections and transfusion safety. In: Murphy MF, Pamphilon DH, Heddle NM, editors. Practical transfusion medicine. 4th ed. Chichester: Wiley; 2013. p. 161-7.
3. Semenza JC, Domanović D. Commentary; blood supply under threat. Nature Clim Change 2013;3:1-6.
4. Woolhouse MEJ, Howey R, Gaunt E, Reilly L, Chase-Topping M, Saville N. Temporal trends in the discovery of human viruses. Proc Roy Soc B 2008;275:2111-5.
5. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases. Nature 2008;451:990-4.
6. Eastlund T, Persing D, Mathiesen D, Kim D, Bieging J, McCann P, Heiler G, Raynovic S. Human granulocytic ehrlichiosis after red cell transfusion [abstract]. Transfusion 1999;39(Suppl):117S.
7. Centers for Disease Control and Prevention. Anaplasma phagocytophilum transmitted through blood transfusion-Minnesota, 2007. Morb Mortal Wkly Rep MMWR 2008;57: 1145-8.
8. Annen K, Friedman K, Eshoa C, Horowitz M, Gottschall J, Straus T. Two cases of transfusion-transmitted Anaplasma phagocytophilum. Am J Clin Pathol 2012;137:562-5.
9. Jareb M, Pecaver B, Tomazic J, Muzlovic I, Avsic-Zupanc T, Premru-Srsen T, Levicnik-Stezinar S, Karner P, Strle F. Severe human granulocytic anaplasmosis transmitted by blood transfusion. Emerg Infect Dis 2012;18:1354-7.
10. Alhumaidan H, Westley B, Esteva C, Berardi V, Young C, Sweeney J. Transfusion-transmitted anaplasmosis from leukoreduced red blood cells. Transfusion 2013;53: 181-6.
11. Townsend RL, Calhoun RD, Fialkow LB, Berardi V, Stramer SL. Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced platelets [abstract]. Transfusion 2013;53:A13-276.
12. Regan J, Matthias J, Green-Murphy A, Stanek D, Bertholf M, Pritt BS, Sloan LM, Kelly AJ, Singleton J, McQuiston JH, Hocevar SN, Whittle JP. A confirmed Ehrlichia ewingii infection likely acquired through platelet transfusion. Clin Infect Dis 2013;56:e105-7.
13. Xu C, Wang R, Schecherly C, Ge S-X, Shih JW-K, Xia N-S, Luban N, Alter HJ. An assessment of hepatitis E virus in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence of HEV transmission to 362 prospectively followed recipients. Transfusion 2013; 53:2505-11.
14. Sakata H, Matsubayashi K, Ihara H, Sato S, Kato T, Wakisaka A, Tadokoro K, Yu M-YW, Baylis SA, Ikeda H, Takamoto S. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors. Transfusion 2013;53:2556-66.
15. Maple P, Beard S, Parry R, Brown K. Testing UK blood donors for exposure to human parvovirus 4 using a timeresolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples. Transfusion 2013;53:2575-84.
16. Baylis SA, Tuke PW, Miyagawa E, Blümel J. Studies on the inactivation of human parvovirus 4. Transfusion 2013;53: 2585-92.
17. Appassakij H, Khuntikij P, Kemapunmanus M, Wutthanarungsan R, Silpapojakul K. Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat? Transfusion 2013;53:2567-74.
18. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Contiflebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140:1481-9.
19. Pas SD, de Man RA, Mulders C, Balk AHMM, van Hal PTW, Weimar W, Koopmans MPG, Osterhaus ADME, van der Eijk AA. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012;18:869-72.
20. Satake M, Hoshi Y, Taira R, Momose S-Y, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011;51: 1887-95.
21. Kleinman SH, Glynn SA, Lee T-H, Tobler L, Montalvo L, Todd D, Kiss JR, Shyamala V, Busch MP. Prevalence and quantitation of parvovirus B19 levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007;47:1756-64.
22. Hourfar MK, Mayr-Wohlfart U, Themann A, Sires W, Seifried E, Schrezenmeier H, Schmidt M. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 2011;51:129-36.
23. Kleinman SH, Glynn SA, Lee T-H, Tobler LH, Schlumpf KS, Todd DS, Qiao H, Yu M-yW, Busch MP. A linked donorrecipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009;114:3677-83.
24. Yu M-yW, Alter HJ, Virata-Theimer MLA, Geng Y, Ma L, Schechterly CA, Colvin CA, Luban NLC. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010;50:1712-21.
25. Charrel RM, de Lamballerie X, Raoult D. Chikungunya outbreaks-the globalization of vectorborne diseases. New Engl J Med 2007;356:769-71.
26. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelinio P, Dottori M, Clufolini MG, Majori GC, Cassone A, CHIKV Study Group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007;370:1840-6.
27. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. Plos Pathog 2007;3: e201.
28. Rasonglès P, Angelini-Tibert MF, Simon P, Currie C, Isola H, Kientz D, Slaedts M, Jacquet M, Sundin D, Lin L, Corash L, Cazenave JP. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a chikungunya virus epidemic in Ile de la Réunion. Transfusion 2009;49:1083-91.
29. Zaki AM, van Boheemen S, Bestebroer T, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814-20.
30. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland M; West Nile Virus Transmission Investigation Team. Transmission ofWest Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
31. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003;349:1205-6.
32. Petersen LR, Epstein JE. Problem solved?West Nile virus and transfusion safety. N Engl J Med 2005;353:516-7.
33. Stramer SL, Markowitz MA. AABB Association Bulletin #13-02-West Nile Virus Nucleic Acid Testing-Revised Recommendations. 2013 [cited 2013 Jun 29]. Available from: URL: http://www.aabb.org/resources/publications/bulletins/Pages/ ab13-02.aspx
34. Meny GM, Santos-Zabala L, Szallasi A, Stramer SL. West Nile virus infection transmitted by granulocyte transfusion. Blood 2011;117:5778.
35. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jeanisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI. The global distribution and burden of dengue. Nature 2013;496:504-7.
36. Stramer SL, Linnen JM, Carrick JM, Foster GA, Krysztof DE, Zou S, Dodd RY, Tirado-Marrero LM, Hunsperger E, Santiago GA, Muñoz-Jordan JL, Tomashek KM. Dengue viremia in blood donors identified by RNA and detection of transfusion transmission during the 2008 dengue outbreak in Puerto Rico. Transfusion 2012;52: 1657-66.
37. Stramer SL, Foster G, Brodsky JP, Muñoz-Jordan JL, Hunsperger E, Lanteri M, Añez-Germán J, Rios M, Cory R, Linnen J. Investigational dengue testing yields high rates of RNA-positive donors in Puerto Rico [abstract]. Transfusion 2013;53:A13-276.
38. Faddy HM, Seed CR, Fryk JJ, Hyland CA, Ritchie SA, Taylor CT, van der Merwe KL, Flower RLP, McBride WJH. Implications of dengue outbreaks for blood supply, Australia. Emerg Infect Dis 2013;19:787-8.
39. Seed CR, Kee G, Wong T, Law M, Ismay S. Assessing the safety of a test-based, targeted donor screening strategy to minimize transfusion- transmitted malaria. Vox Sang 2010;98:182-92.